Simon Daenen
Department of Haematology
University Hospital
Hanzeplein 1
9713 GZ Groningen
Netherlands
Name/email consistency: high
- Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults. Daenen, S., van der Holt, B., Verhoef, G.E., Löwenberg, B., Wijermans, P.W., Huijgens, P.C., van Marwijk Kooy, R., Schouten, H.C., Kramer, M.H., Ferrant, A., van den Berg, E., Steijaert, M.M., Verdonck, L.F., Sonneveld, P. Leuk. Res. (2004)